CCL2 and neoplasm: This is consistent with the established roles of TAMs in promoting tumor progression through immune evasion, angiogenesis, and extracellular matrix remodeling via pathways like CSF1–CSF1R, CCL2–CCR2, and VEGF–VEGFR [36, 37].